Loading company…
Omnia Molecular discovers and develops anti-infective compounds.
Omnia Molecular focuses on discovering and developing new anti-infective compounds. The company is based in Barcelona, Spain, and is at the Series B stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in